These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14671063)

  • 1. Familial mesangio-capillary glomerulonephritis with initial presentation as haemolytic uraemic syndrome.
    Cooper M; McGraw ME; Unsworth DJ; Mathieson P
    Nephrol Dial Transplant; 2004 Jan; 19(1):230-3. PubMed ID: 14671063
    [No Abstract]   [Full Text] [Related]  

  • 2. Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.
    Noris M; Remuzzi G
    Clin Exp Immunol; 2008 Feb; 151(2):199-209. PubMed ID: 18070148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membranoproliferative glomerulonephritis and haemolytic-uraemic syndrome in a patient with congenital chloride diarrhoea.
    Mattoo TK; al Mohrij O; Kagalwalla Y; Said R; Kagalwalla A; Abu-Talib AR
    Nephrol Dial Transplant; 1996 Dec; 11(12):2482-4. PubMed ID: 9017627
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare genetic variant in the CFB gene presenting as atypical hemolytic uremic syndrome and immune complex diffuse membranoproliferative glomerulonephritis, with crescents, successfully treated with eculizumab.
    Alfakeeh K; Azar M; Alfadhel M; Abdullah AM; Aloudah N; Alsaad KO
    Pediatr Nephrol; 2017 May; 32(5):885-891. PubMed ID: 28210841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor H genotype-phenotype correlations: lessons from aHUS, MPGN II, and AMD.
    Goodship TH
    Kidney Int; 2006 Jul; 70(1):12-3. PubMed ID: 16810287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial haemolytic uraemic syndrome.
    Edelsten AD; Tuck S
    Arch Dis Child; 1978 Mar; 53(3):255-6. PubMed ID: 646435
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome.
    Fremeaux-Bacchi V; Dragon-Durey MA; Blouin J; Vigneau C; Kuypers D; Boudailliez B; Loirat C; Rondeau E; Fridman WH
    J Med Genet; 2004 Jun; 41(6):e84. PubMed ID: 15173250
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement factor H and haemolytic uraemic syndrome.
    Mathieson P
    Lancet; 2002 Mar; 359(9308):801-2. PubMed ID: 11888630
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical hemolytic uremic syndrome with membranoproliferative glomerulonephritis.
    Mehta K; More V; Chitale A; Khubchandani S
    Indian Pediatr; 2013 Aug; 50(8):793-4. PubMed ID: 24036644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in three siblings.
    Elias M; Horowitz J; Tal I; Kohn D; Flatau E
    Arch Dis Child; 1988 Jun; 63(6):644-6. PubMed ID: 3389894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined kidney and liver transplantation for familial haemolytic uraemic syndrome.
    Remuzzi G; Ruggenenti P; Codazzi D; Noris M; Caprioli J; Locatelli G; Gridelli B
    Lancet; 2002 May; 359(9318):1671-2. PubMed ID: 12020532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome.
    Vaziri-Sani F; Holmberg L; Sjöholm AG; Kristoffersson AC; Manea M; Frémeaux-Bacchi V; Fehrman-Ekholm I; Raafat R; Karpman D
    Kidney Int; 2006 Mar; 69(6):981-8. PubMed ID: 16528247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular biology in regulation of kidney functions: VEGF (vascular endothelial growth factor)].
    Inoue T; Nonoguchi H
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():302-6. PubMed ID: 16523907
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical approach to primary membranoproliferative glomerulonephritis].
    Fakhouri F
    Nephrol Ther; 2016 Apr; 12 Suppl 1():S65-9. PubMed ID: 26972096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome.
    Sánchez-Corral P; Melgosa M
    Br J Haematol; 2010 Sep; 150(5):529-42. PubMed ID: 20629662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of phenotypes caused by variants in the CFH gene.
    Boon CJ; van de Kar NC; Klevering BJ; Keunen JE; Cremers FP; Klaver CC; Hoyng CB; Daha MR; den Hollander AI
    Mol Immunol; 2009 May; 46(8-9):1573-94. PubMed ID: 19297022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial membranoproliferative glomerulonephritis type III.
    Neary J; Dorman A; Campbell E; Keogan M; Conlon P
    Am J Kidney Dis; 2002 Jul; 40(1):E1. PubMed ID: 12087587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesangio-proliferative glomerulonephritis associated with Kimura's disease.
    Qunibi WY; Al-Sibai MB; Akhtar M
    Clin Nephrol; 1988 Aug; 30(2):111-4. PubMed ID: 3180515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerulonephritis with end-stage liver disease in childhood.
    Noble-Jamieson G; Thiru S; Johnston P; Friend P; Barnes ND
    Lancet; 1992 Mar; 339(8795):706-7. PubMed ID: 1347585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.